vs
Side-by-side financial comparison of AbbVie (ABBV) and ENTERPRISE PRODUCTS PARTNERS L.P. (EPD). Click either name above to swap in a different company.
AbbVie is the larger business by last-quarter revenue ($15.0B vs $14.4B, roughly 1.0× ENTERPRISE PRODUCTS PARTNERS L.P.). ENTERPRISE PRODUCTS PARTNERS L.P. runs the higher net margin — 10.4% vs 4.6%, a 5.8% gap on every dollar of revenue. On growth, AbbVie posted the faster year-over-year revenue change (9.9% vs -6.7%). Over the past eight quarters, ENTERPRISE PRODUCTS PARTNERS L.P.'s revenue compounded faster (3.3% CAGR vs 1.8%).
AbbVie Inc. is an American pharmaceutical company headquartered in North Chicago, Illinois. They have produced drugs to treat a wide range of medical issues.
Enterprise Products Partners L.P. is an American midstream natural gas and crude oil pipeline company with headquarters in Houston, Texas. It acquired GulfTerra in September 2004. The company ranked No. 105 in the 2018 Fortune 500 list of the largest United States corporations by total revenue. Dan Duncan was the majority owner until his death in 2010.
ABBV vs EPD — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $15.0B | $14.4B |
| Net Profit | $697.0M | $1.5B |
| Gross Margin | — | — |
| Operating Margin | 26.6% | 13.2% |
| Net Margin | 4.6% | 10.4% |
| Revenue YoY | 9.9% | -6.7% |
| Net Profit YoY | -46.0% | 6.4% |
| EPS (diluted) | $0.39 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $15.0B | $14.4B | ||
| Q4 25 | $16.6B | $13.8B | ||
| Q3 25 | $15.8B | $12.0B | ||
| Q2 25 | $15.4B | $11.4B | ||
| Q1 25 | $13.3B | $15.4B | ||
| Q4 24 | $15.1B | $14.2B | ||
| Q3 24 | $14.5B | $13.8B | ||
| Q2 24 | $14.5B | $13.5B |
| Q1 26 | $697.0M | $1.5B | ||
| Q4 25 | $1.8B | $1.6B | ||
| Q3 25 | $186.0M | $1.3B | ||
| Q2 25 | $938.0M | $1.4B | ||
| Q1 25 | $1.3B | $1.4B | ||
| Q4 24 | $-22.0M | $1.6B | ||
| Q3 24 | $1.6B | $1.4B | ||
| Q2 24 | $1.4B | $1.4B |
| Q1 26 | — | — | ||
| Q4 25 | 72.6% | 27.0% | ||
| Q3 25 | 66.4% | 28.6% | ||
| Q2 25 | 71.8% | 30.5% | ||
| Q1 25 | 70.0% | 22.1% | ||
| Q4 24 | 70.9% | 25.3% | ||
| Q3 24 | 70.9% | 24.6% | ||
| Q2 24 | 70.9% | 24.5% |
| Q1 26 | 26.6% | 13.2% | ||
| Q4 25 | 27.3% | 14.7% | ||
| Q3 25 | 12.1% | 14.0% | ||
| Q2 25 | 31.7% | 15.8% | ||
| Q1 25 | 28.0% | 11.4% | ||
| Q4 24 | -9.9% | 13.9% | ||
| Q3 24 | 26.5% | 12.9% | ||
| Q2 24 | 27.6% | 13.1% |
| Q1 26 | 4.6% | 10.4% | ||
| Q4 25 | 10.9% | 11.9% | ||
| Q3 25 | 1.2% | 11.1% | ||
| Q2 25 | 6.1% | 12.6% | ||
| Q1 25 | 9.6% | 9.0% | ||
| Q4 24 | -0.1% | 11.4% | ||
| Q3 24 | 10.8% | 10.3% | ||
| Q2 24 | 9.5% | 10.4% |
| Q1 26 | $0.39 | — | ||
| Q4 25 | $1.02 | — | ||
| Q3 25 | $0.10 | — | ||
| Q2 25 | $0.52 | — | ||
| Q1 25 | $0.72 | — | ||
| Q4 24 | $-0.03 | — | ||
| Q3 24 | $0.88 | — | ||
| Q2 24 | $0.77 | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | — |
| Free Cash FlowOCF − Capex | — | $1.9B |
| FCF MarginFCF / Revenue | — | 13.4% |
| Capex IntensityCapex / Revenue | — | 1.4% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $5.2B | $2.5B | ||
| Q3 25 | $7.0B | $1.7B | ||
| Q2 25 | $5.2B | $2.1B | ||
| Q1 25 | $1.6B | $2.3B | ||
| Q4 24 | $7.0B | $2.4B | ||
| Q3 24 | $5.4B | $2.1B | ||
| Q2 24 | $2.3B | $1.6B |
| Q1 26 | — | $1.9B | ||
| Q4 25 | $4.9B | — | ||
| Q3 25 | $6.6B | — | ||
| Q2 25 | $4.9B | $762.0M | ||
| Q1 25 | $1.4B | $1.3B | ||
| Q4 24 | $6.8B | $1.3B | ||
| Q3 24 | $5.2B | $898.0M | ||
| Q2 24 | $2.0B | $310.0M |
| Q1 26 | — | 13.4% | ||
| Q4 25 | 29.4% | — | ||
| Q3 25 | 42.1% | — | ||
| Q2 25 | 31.7% | 6.7% | ||
| Q1 25 | 10.5% | 8.1% | ||
| Q4 24 | 44.7% | 9.1% | ||
| Q3 24 | 35.9% | 6.5% | ||
| Q2 24 | 14.0% | 2.3% |
| Q1 26 | — | 1.4% | ||
| Q4 25 | 2.0% | — | ||
| Q3 25 | 2.4% | — | ||
| Q2 25 | 1.7% | 11.4% | ||
| Q1 25 | 1.8% | 6.9% | ||
| Q4 24 | 1.9% | 7.5% | ||
| Q3 24 | 1.7% | 8.5% | ||
| Q2 24 | 1.7% | 9.4% |
| Q1 26 | — | — | ||
| Q4 25 | 2.87× | 1.50× | ||
| Q3 25 | 37.76× | 1.30× | ||
| Q2 25 | 5.49× | 1.44× | ||
| Q1 25 | 1.27× | 1.66× | ||
| Q4 24 | — | 1.46× | ||
| Q3 24 | 3.49× | 1.46× | ||
| Q2 24 | 1.66× | 1.12× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
